Trial Profile
Administration study for Revolade to healthy Japanese adult males
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Eltrombopag (Primary)
- Indications Acute myeloid leukaemia; Aplastic anaemia; Idiopathic thrombocytopenic purpura; Thrombocytopenia
- Focus Pharmacokinetics
- Sponsors Mitsubishi Chemical
- 09 Jun 2016 New trial record